| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2005 | US6849640 Such as 8-(2,4-dichlorophenyl)-2,3,4,4a,5,9b-hexahydro-1H-pyrido(4,3-b)indole for use as HT3 receptor antagonist, for treatment of depression and obesity |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849637 Matrix metalloproteases (MMPs) inhibitors such as benzyl 4-benzyl-5-oxo-4H-(1,2,4)triazolo(4,3-a)quinazol-7-ylcarboxylate for inflammatory conditions such as rheumatoid arthritis or osteoarthritis, or cancer |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849630 Cyclized amino acid derivatives |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849628 Synthetic diastereoisomers of leucovorin; anticancer agents |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849621 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 02/01/2005 | US6849620 N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | US6849616 Use of estramustine phosphate, a non-nitrogen mustard carbamate derivative of estradiol-17b-phosphate, as a high dose infusion for cancer treatment; also can be used in combination with other chemotherapeutic agents |
| 02/01/2005 | US6849610 A ribonuclease enzyme resistant RNA polynucleotide, for treating human cytomegalovirus infection |
| 02/01/2005 | US6849609 Method and composition for controlled release acarbose formulations |
| 02/01/2005 | US6849608 Macrolide antibiotics |
| 02/01/2005 | US6849606 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849599 Combination drug therapy |
| 02/01/2005 | US6849598 A microbiocides, bactericides, fungicides, comprising a surfactant poloxamer, optionally with EDTA, for treating bacterial infections |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849595 Calorically dense nutritional composition |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849452 Bringing an enriched population of resting NK cells into contact with mature or triggered dendritic cells in vitro or ex vivo, under conditions allowing activation of such resting NK cells by mature or triggered cells |
| 02/01/2005 | US6849448 Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849409 Detecting viricides; obtain sample of cellular kinases, incubate with viricides, detect adjustment in kinase activity, adjustment in activty indicates viricide |
| 02/01/2005 | US6849286 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants |
| 02/01/2005 | US6849281 Food product suitable for reducing low density lipoprotein cholesterol levels |
| 02/01/2005 | US6849277 Composition for moist skin |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | US6849269 Enteric-coated mixture of a poorly water soluble drug and a phospholipid |
| 02/01/2005 | US6849268 Administering especially to an infant or toddler a source of calcium and a fat blend that is low in palmitic acid. |
| 02/01/2005 | US6849267 Screening for modulators kinase activity; obtain sample, incubate with enzyme inhibitor, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 02/01/2005 | US6849266 Lyme disease; enclosure aperture which applies fipronil to parasites on rodents |
| 02/01/2005 | US6849263 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/01/2005 | US6849262 Vascular coating composition |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 02/01/2005 | US6849254 Combination therapy of interferon-alfa and ribavirin in association with Vitamin E and Vitamin C to ameliorate ribavirin-related hemolysis |
| 02/01/2005 | US6849120 Oxidizing 2-((diphenylmethyl)thio)acetamide with hydrogen peroxide in mixture of mineral acid with alcohol or phase transfer catalyst, precipitating solid, and separating |
| 02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
| 02/01/2005 | CA2459622A1 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 02/01/2005 | CA2419729C Crystal form ii of clarithromycin |
| 02/01/2005 | CA2362698C Resorcinol derivatives |
| 02/01/2005 | CA2320448C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines |
| 02/01/2005 | CA2296080C Ophthalmic compositions containing galactomannan polymers and borate |
| 02/01/2005 | CA2270074C Electrically conductive adhesive hydrogels |
| 02/01/2005 | CA2239964C Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
| 02/01/2005 | CA2183976C Process for making an epoxide |
| 02/01/2005 | CA2182024C Method for preparing dry pharmaceutical forms, and resulting pharmaceutical compositions |
| 02/01/2005 | CA2171612C Antioxidant-containing effervescent composition |
| 02/01/2005 | CA2166326C Pyridazinone derivatives |
| 02/01/2005 | CA2156078C New imidazopyridines |
| 02/01/2005 | CA2133324C Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans |
| 02/01/2005 | CA2083159C The combination of growth hormone and insulin-like growth factor-1 enhances growth |
| 01/31/2005 | CA2475968A1 A coating for implantable medical devices to control drug elution from abasecoat |
| 01/31/2005 | CA2436332A1 Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals |
| 01/27/2005 | WO2005014589A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 01/27/2005 | WO2005008250A1 Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway |
| 01/27/2005 | WO2005007889A1 Method for diagnosing colorectal cancers |
| 01/27/2005 | WO2005007876A2 Modulation of interleukin-10 by dhea |
| 01/27/2005 | WO2005007868A2 Controlled platelet activation to monitor therapy of adp antagonists |
| 01/27/2005 | WO2005007862A2 Methionine recovery processes |
| 01/27/2005 | WO2005007845A2 Transgenic cells |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007832A2 System for external control of oncolytic virus replication |
| 01/27/2005 | WO2005007828A2 Regulation of hif protein levels via deubiquitination pathways |
| 01/27/2005 | WO2005007825A2 Modulation of aminopeptidase n expression |
| 01/27/2005 | WO2005007817A2 Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides |
| 01/27/2005 | WO2005007717A1 Thermosensitive polymers for therapeutic use and methods of preparation |
| 01/27/2005 | WO2005007672A2 Small molecule toll-like receptor (tlr) antagonists |
| 01/27/2005 | WO2005007667A1 Curcuminoid glycoside and process for producing the same |
| 01/27/2005 | WO2005007665A2 Lincomycin derivatives possessing antibacterial activity |
| 01/27/2005 | WO2005007652A2 Substituted quinolin-4-ylamine analogues |
| 01/27/2005 | WO2005007651A1 2-acylaminothiazole derivative or salt thereof |
| 01/27/2005 | WO2005007648A2 Biaryl piperazinyl-pyridine analogues |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007646A1 Substituted heterocyclic diarylamine analogues |
| 01/27/2005 | WO2005007644A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/27/2005 | WO2005007640A1 Preventive or therapeutic composition for viral infectious disease |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007632A1 Substituted pyridazinones as inhibitors of p38 |
| 01/27/2005 | WO2005007628A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/27/2005 | WO2005007625A2 Heterocyclic amides with anti-tuberculosis activity |
| 01/27/2005 | WO2005007614A1 Monoamine oxidase inhibitors |
| 01/27/2005 | WO2005007601A2 Substituted arylthiourea derivatives useful as inhibitors of viral replication |
| 01/27/2005 | WO2005007600A2 Novel methods using aminobenzoic acid compounds |
| 01/27/2005 | WO2005007241A1 Parasiticidal composition |
| 01/27/2005 | WO2005007240A1 Combination treatment of neurological disorders comprising phospholipids |
| 01/27/2005 | WO2005007239A1 Use of dapsone as a neuroprotector in cerebral infarction |
| 01/27/2005 | WO2005007192A2 Cytoprotection through the use of hif hydroxylase inhibitors |
| 01/27/2005 | WO2005007191A1 Medicinal composition |
| 01/27/2005 | WO2005007188A1 Methods and compositions for controlling ectoparasites |
| 01/27/2005 | WO2005007180A1 A composition for the improvement of the smell of the armpit |